Magazine
ENEWS
SUBSCRIBE
WEBINARS
PODCASTS
EBOOKS
Edit submissions
Media kit
Innovation Awards
Home
Transgenics to Be a $12 Billion Market by 2012
Feb. 27, 2006
Kalorama analysts expect transgenics to become a $12 billion market by 2012. The first drug approvals using transgenics are expected this year, resulting in a $225 million market. Read about this new report.
Latest from Home
Key drugs losing patent protection in 2025
Michael Annino / Shutterstock AI
Going above and beyond
Pittsburgh’s biotech leap
Michael Annino/Shutterstock AI
Pharma’s new age of longevity
Notable 2024 FDA decisions
Harnessing the power of bispecific antibodies
Load More Content